<DOC>
	<DOCNO>NCT00185380</DOCNO>
	<brief_summary>The purpose study investigate drug dos low one release Mirena® would effective contraception Mirena® . Subjects participate study randomly assign inserted three different intrauterine system ( IUSs ) . The IUSs nearly alike except amount hormone release different .</brief_summary>
	<brief_title>Dose-finding Study Ultralow-dose Levonorgestrel Intrauterine Contraceptive System ( LCS )</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany . Bayer Schering Pharma AG , Germany sponsor trial . Although title study describe `` open '' , fact single-blinded . Issues side effect address Adverse Event section .</detailed_description>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Women without child good general health need contraception . Regular menstrual cycle without hormonal contraceptive . Pregnant lactating . Last delivery abortion le 12 week ago . Previous pregnancy outside womb . Previous pelvic infection . Abnormal bleeding . Abnormal uterine cavity . Climacteric sign . Genital cancer . Liver diseases . Alcoholism drug abuse .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>